In recent years, a number of preclinical models have shown that cannabinoids may be highly effective at improving inflammation and, therefore, may be a potential treatment for inflammatory bowel diseases.
Up to 40% of Clostridioides difficile infections are community-associated in patients without any significant risk factors such as recent antibiotics, hospitalization, advanced age, inflammatory bowel disease, or history of malignancy.
Very early onset inflammatory bowel disease (IBD) is the fastest-growing incidence of IBD in some patient populations. This condition, defined as IBD presenting before 6 years of age, is often represented by the presence of monogenic etiologies.
A growing body of research points to the role of the gut-brain axis in the development of Parkinson disease, with inflammatory bowel disease, leaky gut, and altered gut microbiota observed in the gut, often years before the onset of symptoms of Parkinson disease.
From pay disparities, and overt sexual harassment to policies that disproportionately affect working or expecting mothers, women across the medical spectrum face challenges not seen by their male colleagues.
Until the healthcare industry can more adequately handle big data, adapt to artificial intelligence, and gather more evidence surrounding the efficacy of precision medicine for CRC, healthcare providers and patients must remain aware of hype, while also remaining optimistic about the hope of the individualized treatment and prevention of CRC.